Pfizer consumer health care sales up 10% to $409 mil. in 1994.
This article was originally published in The Tan Sheet
Executive Summary
PFIZER CONSUMER HEALTH CARE SALES UP 10% IN 1994 to $409 mil. worldwide with growth from both U.S. and international operations. Sales for consumer health care products in the U.S. rose 4% to $274 mil., while international sales increased 22% to $135 mil. The company said its leading consumer brands, Desitin, Unisom, Ben-Gay and Rid, all recorded market-share increases during the year
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.